Exact Mass: 298.1351874
Exact Mass Matches: 298.1351874
Found 500 metabolites which its exact mass value is equals to given mass value 298.1351874,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Trimeprazine
Trimeprazine is only found in individuals that have used or taken this drug. It is a phenothiazine derivative that is used as an antipruritic. [PubChem]Trimeprazine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AD - Phenothiazine derivatives C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic D003879 - Dermatologic Agents > D000982 - Antipruritics
Enterolactone
Enterolactone (CAS: 78473-71-9) is a mammalian lignan that has a similar biphenolic structure to lignans from plants. Lignans are compounds with estrogenic properties and are probably the most important source of phytoestrogens in western diets. Mammalian lignans are formed from precursors that are contained mainly in vegetables, whole grain products, and berries, via the action of intestinal microflora. Enterolactone is produced in the colon by the action of bacteria on secoisolariciresinol, matairesinol, and its glycosides. Secoisolariciresinol is converted to enterodiol which is subsequently converted to enterolactone as it passes through the colon. Matairesinol is converted directly to enterolactone. Enterolactone has been shown to possess weakly estrogenic and antiestrogenic activities, and it has been suggested that the high production of this antiestrogenic mammalian lignans in the gut may serve to protect against breast cancer in women and prostate cancer in men; however epidemiological evidence to date is conflicting (PMID: 16168401, 12270221, 11216511, 12107024). Enterolactone is a biomarker for the consumption of soybeans and other soy products. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens
Olomoucine
Olomoucine is found in root vegetables. Olomoucine is a constituent of the cotyledons of radish D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins Constituent of the cotyledons of radish. Olomoucine is found in root vegetables. D004791 - Enzyme Inhibitors
7-Methylguanosine
7-methylguanosine is an endogenous methylated nucleoside found in human fluids; methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls.DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, the DNA becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. 7-Methylguanosine is a substrate for purine-nucleoside phosphorylase and Eukaryotic translation initiation factor 4E. (PMID: 3506820, 17044778, 17264127, 16799933) [HMDB] 7-methylguanosine is an endogenous methylated nucleoside found in human fluids; methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls.DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, the DNA becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. 7-Methylguanosine is a substrate for purine-nucleoside phosphorylase and Eukaryotic translation initiation factor 4E. (PMID:3506820, 17044778, 17264127, 16799933).
Toxin T2 tetrol
T-2 Tetraol is a type-A trichothecene mycotoxin produced by different Fusarium species, including F. soprotrichioides, F. poae, and F. acuinatum that contaminate feedstuffs and cereal grains (PMID: 11843402, 31683661). T-2 Tetraol shows the highest toxicity in animals compared to other trichothecenes. It contains a tetracyclic sesquiterpenoid 12,13-epoxytrichothec-9-ene ring which is responsible for the high toxicological activity (PMID: 12749813). In T-2 Tetraol, a carbonyl group at the C-8 position is substituted by an ester. T-2 Tetraol is resistant to light and temperature, but sensitive to strong acid or alkaline conditions. Some coexisting bacteria or fungi can detoxify T-2 Tetraol by altering its structure. It is associated with a wide range of effects in animals including weight loss, diarrhea, lethargy, low plasma glucose, decreases in blood cell and leukocyte count. damage to cartilaginous tissues, and induction of apoptosis (PMID: 21417259). D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins Mycotoxin from Fusarium poae and Fusarium sporotrichioides
3,7,8,15-Scirpenetetrol
3,7,8,15-Scirpenetetrol is a mycotoxin from Fusarium graminearum. Mycotoxin from Fusarium graminearum
(+)-Ligballinol
(+)-ligballinol is a member of the class of compounds known as furanoid lignans. Furanoid lignans are lignans with a structure that contains either a tetrahydrofuran ring, a furan ring, or a furofuan ring system, that arises from the joining of the two phenylpropanoid units (+)-ligballinol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). (+)-ligballinol can be found in pulses, which makes (+)-ligballinol a potential biomarker for the consumption of this food product. (+)-Ligballinol is found in pulses. (+)-Ligballinol is a stress metabolite of cell cultures of Vigna angularis (azuki bean
1-(2,4-Dihydroxy-6-methoxy-3,5-dimethylphenyl)-3-phenyl-2-propen-1-one
1-(2,4-Dihydroxy-6-methoxy-3,5-dimethylphenyl)-3-phenyl-2-propen-1-one is found in herbs and spices. 1-(2,4-Dihydroxy-6-methoxy-3,5-dimethylphenyl)-3-phenyl-2-propen-1-one is isolated from Myrica gale (bog myrtle). Isolated from Myrica gale (bog myrtle). 1-(2,4-Dihydroxy-6-methoxy-3,5-dimethylphenyl)-3-phenyl-2-propen-1-one is found in herbs and spices.
7-Hydroxy-5-methoxy-6,8-dimethylflavanone
7-Hydroxy-5-methoxy-6,8-dimethylflavanone is found in fruits. 7-Hydroxy-5-methoxy-6,8-dimethylflavanone is a constituent of Eugenia javanica (Java apple)
5,7-Dimethoxy-6-methylflavanone
5,7-Dimethoxy-6-methylflavanone is found in tea. 5,7-Dimethoxy-6-methylflavanone is a constituent of Leptospermum scoparium (red tea). Constituent of Leptospermum scoparium (red tea). 5,7-Dimethoxy-6-methylflavanone is found in tea.
7C-aglycone
7C-aglycone is one of the two major aglycone urinary water-soluble metabolites of Phylloquinone (Vitamin K1) and menaquinones (vitamin K2), usually excreted as glucuronide conjugates; their structure suggests that they are formed by an oxidative degradation of the phytyl side chain involving enzymes of omega- and beta-oxidation. Newborn infants as a group, are known to have precariously low vitamin K stores and are routinely given vitamin K prophylaxis at birth. (PMIDs 7306367, 4833371, 15722567) [HMDB] 7C-aglycone is one of the two major aglycone urinary water-soluble metabolites of Phylloquinone (Vitamin K1) and menaquinones (vitamin K2), usually excreted as glucuronide conjugates; their structure suggests that they are formed by an oxidative degradation of the phytyl side chain involving enzymes of omega- and beta-oxidation. Newborn infants as a group, are known to have precariously low vitamin K stores and are routinely given vitamin K prophylaxis at birth. (PMIDs 7306367, 4833371, 15722567).
N-Desmethyl Olanzapine
C16H18N4S (298.12521080000005)
4-N-desmethylolanzapine is a metabolite of olanzapine. Olanzapine (trade name Zyprexa or in combination with fluoxetine Symbyax) is an atypical antipsychotic, approved by the FDA for the treatment of schizophrenia and bipolar disorder. Olanzapine is structurally similar to clozapine, but is classified as a thienobenzodiazepine. The olanzapine formulations are manufactured and marketed by the pharmaceutical company Eli Lilly and Company; the drug went generic in 2011. Sales of Zyprexa in 2008 were $2.2B in the US alone, and $4.7B in total. (Wikipedia)
LysoPA(8:0/0:0)
LysoPA(8:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(8:0/0:0), in particular, consists of one chain of caprylic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
(E)-3-(2,3-Dimethoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
Bilin
Corrole
Nialamide
N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AF - Monoamine oxidase inhibitors, non-selective D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor
Nvp dpp 728 dihydrochloride
Piribedil
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist Piribedil is a potent and orally active dopamine D2 and dopamine D3 agonist. Piribedil is also a α2-adrenoceptors antagonist. Piribedil can inhibit MLL1 methyltransferase activity (EC50: 0.18 μM). Piribedil has the potential for the research of parkinson's disease, circulatory disorders, cancers[1][2][3][4].
Infectocaryone
Hofmeisterin II
A natural product found in Eupatorium cannabinum subspecies asiaticum.
2,4-Dihydroxy-6-methoxy-3,5-dimethylchalcone
A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 2 and 4, a methoxy group at position 6 and methyl groups at positions 3 and 5. Isolated from the buds of Cleistocalyx operculatus, it has been shown to exhibit inhibitory effects on the viral neuraminidases from two influenza viral strains, H1N1 and H9N2.
2-(1-Methyl-1H-pyrrol-2-yl)-3-(3,4,5-trimethoxyphenyl)acrylonitrile
(5-amino-3-triazolo[1,5-a]quinazolinyl)-(4-morpholinyl)methanone
N1-Acetyl-2-cyano-3-(4-phenylpiperazino)acrylamide
Nialamide
N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AF - Monoamine oxidase inhibitors, non-selective D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor
Hydroheptilidic-acid
[Raw Data] CBA58_Hydrohepteli_pos_50eV.txt [Raw Data] CBA58_Hydrohepteli_pos_40eV.txt [Raw Data] CBA58_Hydrohepteli_pos_30eV.txt [Raw Data] CBA58_Hydrohepteli_pos_20eV.txt [Raw Data] CBA58_Hydrohepteli_pos_10eV.txt
3-phenyl-1-(2,4,6-trimethoxyphenyl)prop-2-en-1-one
1-(2,4-dihydroxy-6-[(1E)-2-(4-hydroxyphenyl)ethenyl]-phenyl)-2-methyl-1-propanone|1-{2,4-dihydroxy-6-[(1E)-2-(4-hydroxyphenyl)ethenyl]phenyl}-2-methyl-1-propanone
(7S,8S)-2,4-dihydroxy-7,3-epoxy-8,4-oxyneolign-7-ene|4-[(2S,3S)-3-Methyl-7-((E)-1-propenyl)-2,3-dihydro-1,4-benzodioxin-2-yl]-1,3-benzenediol
1-alpha-hydroxy-3-deoxypseudoanisatin|1alpha-hydroxy-3-deoxypseudoanisatin|1??-Hydroxy-3-deoxypseudoanisatin
4E-1beta-hydroperoxy-3beta,11beta-dihydroxygermacra-4(5),10(14)-dien-12,6alpha-olide
1-(2,4-dimethoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
5-(erythro-1,2-dihydroxypropyl)-2-(4-hydroxyphenyl)-3-methylbenzofuran
rel-5-(1R,5S-dimethyl-3R,4R,8S-trihydroxy-7-oxabicyclo[3,2,1]oct-8-yl)-3-methyl-2Z,4E-pentadienoic acid
2-isopropyl-5-methyl-p-hydroquinone-4-O-beta-xylopyranoside
1alpha-hydroxy-6-deoxypseudoanisatin|1??-Hydroxy-6-deoxypseudoanisatin
2-C-methyl-D-erythritol 3-O-beta-D-glucopyranoside|2-C-Methyl-D-erythritol 3-O-??-D-glucopyranoside
(3-Phenyl-propyl)-beta-D-glucopyranosid|(3-phenyl-propyl)-beta-D-glucopyranoside|3-phenyl-1-propanol beta-D-glucopyranoside|3-phenylpropan-1-ol beta-D-glucopyranoside|3-phenylpropyl beta-D-glucopyranoside
amentotaxin WB|rel-(3R,3aS,10bR)-3a,4,6,10b-tetrahydro-5-hydroxy-3,6,6-trimethyl-2H-benzo[5,6]indeno[1,2-b]furan-2,7(3G)-dione
2-C-methyl-D-erythritol 4-O-beta-D-fructofuranoside|2-C-Methyl-D-erythritol 4-O-??-D-fructofuranoside
2,2,4-trimethyl-6-(1-oxo-3-phenylprop-2-enyl)cyclohexane-1,3,5-trione|5-hydroxydesmosdumotin C|champanone B
2-trans-Cinnamoyl-3-hydroxy-5-methoxy-6,6-dimethyl-cyclohexa-2,4-dienon|2-trans-cinnamoyl-3-hydroxy-5-methoxy-6,6-dimethyl-cyclohexa-2,4-dienone|4-Hydroxy-6-methoxy-1.1-dimethyl-3-trans-cinnamoyl-cyclohexadien-(3.5)-on-(2)|ceroptene
(2R,2aR,4aS,5R,8R,8aS,8bS,9S)-octahydro-2,2a-dihydroxy-9-(2-hydroxy-1-methylethyl)-8b-methyl-5,6-methano-1,7dioxacyclopent[cd]azulen-6(2H)-one|dendronobilin C
3alpha-hydroxy-5beta-(4-hydroxytigloyloxy)-7-hydroxycarvotanacetone
2-Isobutyl-5-(1H-indole-3-yl)oxazole-4-carboxylic acid methyl ester
(E)-9-(3,4-dimethylpent-2-enyloxy)-7H-furo[3,2-g]chromen-7-one
1,1,7-Trimethyl-3-methoxy-6,9-dihydroxy-1,2-dihydrophenanthrene-2-one
(2aR,10aS)-3t,4,10t-Trihydroxy-2a,3c,8c-trimethyl-(2ar)-hexahydro-4c,7ac-methano-cyclopent[b]oxeto[2,3-c]oxocin-6-on|(2aR,10aS)-3t,4,10t-trihydroxy-2a,3c,8c-trimethyl-(2ar)-hexahydro-4c,7ac-methano-cyclopent[b]oxeto[2,3-c]oxocin-6-one
Tetra-Me ether-1,5-Di-Me ether-1,2,5,7-Tetrahydroxyphenanthrene
2-(Dimethylamino)-5-(1H-indole-3-yl)-5-(2-oxopropyl)-2-imidazoline-4-one
2-C-methyl-D-erythritol 3-O-beta-D-fructofuranoside|2-C-Methyl-D-erythritol 3-O-??-D-fructofuranoside
2-C-methyl-D-erythritol 1-O-beta-D-glucopyranoside|2-C-Methyl-D-erythritol 1-O-??-D-glucopyranoside
2-C-methyl-D-erythritol 1-O-beta-D-fructofuranoside|2-C-Methyl-D-erythritol 1-O-??-D-fructofuranoside
7,9,10-trihydroxy-4-oxobisabol-2,11-dien-13-oic acid
3-deoxy-10alpha(14)-epoxy-11alpha,13-dihydroxy-11,13-dihydroamphoricarpolide
2-C-methyl-D-erythritol 4-O-beta-D-glucopyranoside|2-C-Methyl-D-erythritol 4-O-??-D-glucopyranoside
3-(3,4,5-Trimethoxyphenyl)-3-methoxy-1-propanol acetate
2,4-Dihydroxy-3,7:4,8-diepoxylign-7-ene
Phenethyl ferulate
Phenylethyl 3-methylcaffeate is a natural product found in Hansenia forbesii, Hansenia weberbaueriana, and Propolis with data available. Phenethyl ferulate is a major constituent ofQianghuo, shows inhibitory activity against cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) with IC50 values of 4.35 μM and 5.75 μM, respectively[1]. Phenethyl ferulate is a major constituent ofQianghuo, shows inhibitory activity against cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) with IC50 values of 4.35 μM and 5.75 μM, respectively[1]. Phenethyl ferulate is a major constituent ofQianghuo, shows inhibitory activity against cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) with IC50 values of 4.35 μM and 5.75 μM, respectively[1].
N-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]amino}(3-methoxyphenyl)carboxamide
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.393 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.395
3-hydroxy-4-(2,6,7-trihydroxy-6-methylheptan-2-yl)benzoic acid
C15H22O6_(2E)-3-[(3aS,4S,5R,7aS)-7a-Hydroxy-5-isopropyl-3-oxooctahydro-2-benzofuran-4-yl]-2-(hydroxymethyl)acrylic acid
C15H22O6_(3beta,4alpha,8alpha)-12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol
C15H22O6_Methyl 2-(1,3,5-trihydroxy-4a-methyl-8-oxodecahydro-2-naphthalenyl)acrylate
7-Methylguanosine
A positively charged methylguanosine in which a single methyl substituent is located at position 7.
Enterolactone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens CONFIDENCE standard compound; INTERNAL_ID 483; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3951; ORIGINAL_PRECURSOR_SCAN_NO 3949 CONFIDENCE standard compound; INTERNAL_ID 483; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3959; ORIGINAL_PRECURSOR_SCAN_NO 3958 CONFIDENCE standard compound; INTERNAL_ID 483; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3921; ORIGINAL_PRECURSOR_SCAN_NO 3919 CONFIDENCE standard compound; INTERNAL_ID 483; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3952; ORIGINAL_PRECURSOR_SCAN_NO 3950 CONFIDENCE standard compound; INTERNAL_ID 483; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3939; ORIGINAL_PRECURSOR_SCAN_NO 3935 CONFIDENCE standard compound; INTERNAL_ID 483; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3939; ORIGINAL_PRECURSOR_SCAN_NO 3937 Annotation level-1
[2-[(E)-3,4-dihydroxypent-1-enyl]-6-oxooxan-3-yl] (E)-2-methylbut-2-enoate
methyl 2-(1,3,5-trihydroxy-4a-methyl-8-oxo-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl)prop-2-enoate
T-2 Tetraol
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE isolated standard
trimeprazine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AD - Phenothiazine derivatives C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic D003879 - Dermatologic Agents > D000982 - Antipruritics
T-2 Tetraol
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
methyl 2-(1,3,5-trihydroxy-4a-methyl-8-oxo-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl)prop-2-enoate_major
[2-[(E)-3,4-dihydroxypent-1-enyl]-6-oxooxan-3-yl] (E)-2-methylbut-2-enoate_major
2-Furanpropanoic acid, tetrahydro-4-(1-naphthalenylmethyl)-5-oxo-
olomoucine
D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins D004791 - Enzyme Inhibitors
Idebenone Metabolite (Benzenehexanoic acid, 2,5-dihydroxy-3,4-dimethoxy-6-methyl-)
T2 Tetrol
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
3,7,8,15-Scirpenetetrol
Methyl 2-(1,3,5-trihydroxy-4a-methyl-8-oxodecahydro-2-naphthalenyl)acrylate
(3S,6S,8AS)-6-((TERT-BUTOXYCARBONYL)AMINO)-5-OXOOCTAHYDROINDOLIZINE-3-CARBOXYLIC ACID
5-(1,2-DIHYDROXY-2-(PYRIDIN-4-YL)ETHYL)-2,3-DIHYDRO-1H-INDEN-1-ONE O-METHYL OXIME
Ivachtin
A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05B - Liver therapy, lipotropics > A05BA - Liver therapy D002491 - Central Nervous System Agents > D000427 - Alcohol Deterrents
tert-Butyl 4-(2-chloropyrimidin-4-yl)piperazine-1-carboxylate
C13H19ClN4O2 (298.11964639999997)
tert-Butyl 4-(4-chloropyrimidin-2-yl)piperazine-1-carboxylate
C13H19ClN4O2 (298.11964639999997)
1-Boc-4-(6-Chloropyridazin-3-yl)piperazine
C13H19ClN4O2 (298.11964639999997)
diethazine
C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent
1,2-BINAPHTHALEN]-4-YLBORONIC ACID
C20H15BO2 (298.11650399999996)
4-TRIFLUOROMETHYL-TRANS-BETA-STYRYLBORONIC ACID PINACOL ESTER
BENZYL 2-PROPYLPIPERAZINE-1-CARBOXYLATE HYDROCHLORIDE
2-[2-[4-(dimethylamino)phenyl]ethenyl]-5-nitrobenzene-1,4-diamine
E-2-(3-Trifluoromethylphenyl)vinylboronic acid pinacol ester
3-(2-(Pyrrolidin-1-yl)ethylcarbamoyl)phenylboronic acid, HCl
Vortioxetine
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants D049990 - Membrane Transport Modulators Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Vortioxetine is a inhibitor of 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT, with Ki values of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.
TERT-BUTYL 2-(3-OXOISOINDOLIN-4-YL)-1H-PYRROLE-1-CARBOXYLATE
(4-((2-(PYRROLIDIN-1-YL)ETHYL)CARBAMOYL)PHENYL)BORONIC ACID HYDROCHLORIDE
4-(4-phenylphenyl)-2,3-dihydro-1H-1,5-benzodiazepine
[4-(6-FORMYLPYRIDIN-2-YL)PHENYL]CARBAMIC ACID TERT-BUTYL ESTER
METHYL 3,4-DIFLUORO-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE
piprozolin
C78276 - Agent Affecting Digestive System or Metabolism > C66913 - Cholagogues or Choleretic Agents A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05A - Bile therapy
tert-butyl 4-[4-(hydroxymethyl)-1,3-thiazol-2-yl]piperidine-1-carboxylate
N-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL)ACETAMIDE HYDROCHLORIDE
methyl N-[(3R,4R)-1-benzyl-4-methylpiperidin-3-yl]carbamate
2-[(4-Chlorophenyl)(1-methyl-4-piperidinylidene)methyl]pyridine
tert-butyl 4-(3-chloropyrazin-2-yl)piperazine-1-carboxylate
C13H19ClN4O2 (298.11964639999997)
tert-Butyl 4-(6-chloropyrimidin-4-yl)piperazine-1-carboxylate
C13H19ClN4O2 (298.11964639999997)
2-[1,4]Diazepan-1-yl-5-propyl-benzenesulfonic acid
N-(4-ethoxyphenyl)-4-oxo-1,5,6,7-tetrahydroindole-3-carboxamide
3-(Boc-amino)-3-(4-fluorophenyl)-N-hydroxypropanamide
tert-butyl 4-(6-chloropyrazin-2-yl)piperazine-1-carboxylate
C13H19ClN4O2 (298.11964639999997)
N-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YL)METHANESULFONAMIDE
C12H19BN2O4S (298.11585240000005)
5-tert-butylsulfonyl-2-piperidin-1-ylpyrimidin-4-amine
N-cyclopentyl-2-methyl-5-(3-nitrophenyl)pyrimidin-4-amine
N-cyclopentyl-2-methyl-5-(4-nitrophenyl)pyrimidin-4-amine
(10-Phenylanthracen-9-yl)boronic acid
C20H15BO2 (298.11650399999996)
2-(4-ethylpiperazin-1-ylsulfonyl)phenylboronic acid
C12H19BN2O4S (298.11585240000005)
2-trifluoromethyl-trans-beta-styrylboronic acid pinacol ester
1-(4-Fluorophenyl)-5-methyl-2-phenylhexane-1,4-dione
Boronic acid, B-[4-[(4-ethyl-1-piperazinyl)sulfonyl]phenyl]-
C12H19BN2O4S (298.11585240000005)
B-[1,1-Binaphthalen]-4-ylboronic acid
C20H15BO2 (298.11650399999996)
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-naphthoic acid
C17H19BO4 (298.13763240000003)
6-Methoxypyridine-2-boronic acid N-phenyldiethanolamine ester
Benzenepropanoic acid, b-hydroxy-b-phenyl-, 2-acetylhydrazide
Methyl 3,5-difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
4-ETHYLAMINO-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER-HCl
benzyl (2R)-2-propan-2-ylpiperazine-1-carboxylate,hydrochloride
benzyl (2R)-2-propylpiperazine-1-carboxylate,hydrochloride
benzyl (2S)-2-propylpiperazine-1-carboxylate,hydrochloride
Pamiparib
C16H15FN4O (298.12298319999996)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XK - Poly (adp-ribose) polymerase (parp) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor
Ethyl 8-hydroxy-alpha-(2-propynylamino)-5-quinolinepropanoate
(E)-4-methyl-6-(3-methyl-1,4-dioxonaphthalen-2-yl)hex-4-enoic acid
(E)-3-(2,3-Dimethoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
(E)-2-(Hydroxymethyl)-3-[(3aalpha)-3-oxo-5beta-isopropyl-7aalpha-hydroxyoctahydroisobenzofuran-4alpha-yl]acrylic acid
Isopropyl 2-amino-5-[(diethylamino)carbonyl]-4-methylthiophene-3-carboxylate
N-(4-acetylphenyl)-5,6,7,8-tetrahydro-4H-cyclohepta[d]isoxazole-3-carboxamide
3-Chloro-9-ethyl-6,7,8,9,10,11-hexahydro-7,11-methanocycloocta[B]quinolin-12-amine
(2S)-5-(dimethylamino)-9-methyl-2-prop-2-enylpyrazolo[1,2-a][1,2,4]benzotriazine-1,3-dione
Piribedil
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist Piribedil is a potent and orally active dopamine D2 and dopamine D3 agonist. Piribedil is also a α2-adrenoceptors antagonist. Piribedil can inhibit MLL1 methyltransferase activity (EC50: 0.18 μM). Piribedil has the potential for the research of parkinson's disease, circulatory disorders, cancers[1][2][3][4].
2-(2-Hydroxy-4-methoxyphenyl)-5-(3-hydroxypropyl)benzofuran
A member of the class of benzofurans that is 1-benzofuran substituted by a 2-hydroxy-4-methoxyphenyl group at position 2 and a 3-hydroxypropyl group at position 5. It is a lignan derivative isolated from the roots of Krameria lappacea.
5-(3-Hydroxypropyl)-2-(2-methoxy-4-hydroxyphenyl)benzofuran
A member of the class of benzofurans that is 1-benzofuran substituted by a 3-hydroxypropyl group at position 5 and a 4-hydroxy-2-methoxyphenyl group at position 2. It is a lignan derivative isolated from the roots of Krameria lappacea.
Neopinone(1+)
The trialkylammonium ion resulting from the protonation of the amino group of neopinone.
N-propanoyl-gamma-L-glutamyl-L-orornithine-delta-lactam
(2S,4R)-4-(hydroxymethyl)-6-(4-nitroanilino)cyclohexane-1,2,3-triol
(5R,6S)-3-(5-azaniumyl-2-methylpentan-2-yl)-6-[(1R)-1-hydroxyethyl]-7-oxo-4-oxa-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
(5R,6S)-3-(5-amino-2-methylpentan-2-yl)-6-[(1R)-1-hydroxyethyl]-7-oxo-4-oxa-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5E)-2-[(E)-pyrrol-2-ylidenemethyl]-5-[[(5E)-5-(1H-pyrrol-2-ylmethylidene)pyrrol-2-yl]methylidene]pyrrole
(2S)-5-hydroxy-7-methoxy-6,8-dimethylflavanone
A monohydroxyflavanone that is (2S)-flavanone substituted by a hydroxy group at position 5, a methoxy group at position 7 and methyl groups at positions 6 and 8. It has been isolated from the buds of Cleistocalyx operculatus.
3-[(Pyrazine-2-carbonyl)-hydrazono]-N-pyridin-2-yl-butyramide
2-imino-10-propyltetrahydro-8a,3-(epoxymethano)chromene-3,4,4(2H,4aH)-tricarbonitrile
N-[6-(1-oxopentylamino)-3-pyridinyl]-3-pyridinecarboxamide
N-(4-{[2-(1H-pyrrol-2-ylmethylene)hydrazino]carbonyl}phenyl)butanamide
2-{4-[3-(5-Methyl-2-furyl)acryloyl]-1-piperazinyl}pyrimidine
5-Methyl-N-[4-(4-morpholinyl)phenyl]-2-pyrazinecarboxamide
N-[4-methyl-6-(1-oxobutylamino)-3-pyridinyl]-4-pyridinecarboxamide
2-[[2-(4-Methoxyphenyl)-5-methyl-7-pyrazolo[1,5-a]pyrimidinyl]amino]ethanol
(4bS,6aS,9aS,9bR)-6a-methyl-7-oxo-5,6,6a,7,8,9,9a,9b,10,11-decahydro-4bH-indeno[5,4-f]quinoline-2-carboxylate
N-[2-(3-methoxyanilino)-2-oxoethyl]-4-methylbenzamide
1-Phenyl-3-(2-phenyldiazenylpropan-2-yl)thiourea
C16H18N4S (298.12521080000005)
2-[3-(2-Oxo-1-pyrrolidinyl)propyliminomethyl]indene-1,3-dione
1-(3,4-Dimethoxyphenyl)-3-[(5-methyl-2-pyridinyl)imino]-1-propanone
(6E)-6-(naphthalen-2-ylmethylidene)-8,9-dihydro-7H-benzo[7]annulen-5-one
5-Isopentyl-6-methyl-2-(methylsulfanyl)-4-pyrimidinol, TMS derivative
C14H26N2OSSi (298.15350259999997)
3-Hydroxy-4-(2,6,7-trihydroxy-6-methylheptan-2-yl)benzoic acid
1-(2-Hydroxy-6-methoxyphenyl)-5-phenyl-1,3-pentanedione
1-(2-Hydroxy-5-methoxyphenyl)-5-phenyl-1,3-pentanedione
2-[3-(4-Methoxybenzoyl)phenyl]propionic acid methyl ester
2-[3-(3-Methoxybenzoyl)phenyl]propionic acid methyl ester
8,9-Diphenyltricyclo(5,2,1,0(2,6))deca-4,8-dien-3-one
(4S)-N-[1-(Methoxycarbonyl)-3-butenyl]-2-oxo-4beta-(tert-butyl)oxazolidine-3-carboxamide
oripavine(1+)
The trialkylammonium ion resulting from the protonation of the amino group of oripavine; Major species at pH 7.3.
N-Desmethylolanzapine
C16H18N4S (298.12521080000005)
2-methyl-3-[(2E)-5-carboxy-3-methylpent-2-enyl]-1,4-naphthoquinone
A member of the class of naphthoquinones that is 2-methyl-1,4-naphthoquinone which is substituted at position 3 by a (2E)-5-carboxy-3-methylpent-2-en-1-yl group. A urinary metabolite of vitamin K1.
pyridinestrone-3-carboxylate
A steroid acid anion, that is the conjugate base of pyridinestrone-3-carboxylic acid. An abiotic metabolite in the 4,5-seco pathway of aerobic estrogen degradation by the bacterium Sphingomonas sp. strain KC8.
p-Ts-L-Lys-Me
A methyl ketone that is L-lysine with an alpha-amine hydrogen substituted with a 4-methylbenzenesulfonamide (tosyl) group and a methyl group replacing the hydroxy of the carboxylic acid.
(2r)-5-hydroxy-6,8,8-trimethyl-2-phenyl-2,3-dihydro-1-benzopyran-4,7-dione
(3s,3as,6r,7s,8r,8ar)-6,8-dihydroxy-3,6,8-trimethyl-tetrahydro-3h-spiro[cyclohepta[b]furan-7,2'-oxolane]-2,5'-dione
5,9,11,13-tetrahydroxy-2,6,10-trimethyl-8-oxatetracyclo[7.3.1.0¹,⁵.0⁶,¹⁰]tridecan-4-one
{9-methoxy-4,5-dimethylnaphtho[2,3-b]furan-3-yl}methyl acetate
4-[(1s,3ar,4s,6ar)-4-(4-hydroxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]phenol
7-isopropyl-3,3,4-trimethylnaphtho[2,3-b]furan-2,5,6-trione
methyl 2-(n-hydroxyimino)-3-[7-(3-methylbuta-1,3-dien-1-yl)-1h-indol-3-yl]propanoate
(2s)-5-hydroxy-7-methoxy-6,8-dimethyl-2-phenyl-2,3-dihydro-1-benzopyran-4-one
(1s,2r,4r,6r,7r,8s,9r,12s)-2,8-dihydroxy-6-(hydroxymethyl)-12-isopropyl-7-methyl-5,10-dioxatetracyclo[7.2.1.0²,⁷.0⁴,⁶]dodecan-11-one
7-hydroperoxy-3,9-dihydroxy-3,10-dimethyl-6-methylidene-3ah,4h,5h,7h,8h,9h,11ah-cyclodeca[b]furan-2-one
4,5,7,9-tetrahydroxy-4a,8-dimethyl-3-methylidene-octahydro-3ah-azuleno[6,5-b]furan-2-one
2-(hydroxymethyl)-5-methoxy-7-(3-methyl-2-oxobut-3-en-1-yl)naphthalene-1-carbaldehyde
3,4,6-trihydroxy-6-(4-methyl-5-oxocyclohex-3-en-1-yl)-2-methylideneheptanoic acid
2-hydroxy-4,4,14-trimethyl-12-oxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-1,3(8),6,9-tetraene-5,13-dione
(1r,2r,5r,7s,10s)-10-hydroperoxy-2-isopropyl-5-methyl-11,12-dioxatricyclo[5.3.2.0¹,⁵]dodec-8-ene-8-carboxylic acid
3-(4-hydroxyphenyl)propyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
4',6,7-trihydroxy-6',7-dimethyl-1,4,5,6-tetrahydrospiro[2-benzopyran-3,2'-oxan]-8-one
(2s,3r)-5-[2-hydroxy-5-(prop-2-en-1-yl)phenyl]-2-(hydroxymethyl)-2,3-dihydro-1-benzofuran-3-ol
(2r)-2,3-dihydroxy-2-(2-hydroxy-5-methoxy-4-methylphenyl)propyl 2-methylpropanoate
2',5,6-trihydroxy-2',4,4'-trimethyl-3'a,4',5',7'a-tetrahydrospiro[cyclohexane-1,3'-furo[2,3-c]pyra]-3-en-7'-one
(3r,4's,6r,6's,7r)-4',6,7-trihydroxy-6',7-dimethyl-1,4,5,6-tetrahydrospiro[2-benzopyran-3,2'-oxan]-8-one
2'-(hydroxymethyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-ene-3',4',10'-triol
(11r,14r,15s)-2-hydroxy-4,4,14-trimethyl-12-oxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-1,3(8),6,9-tetraene-5,13-dione
(1's,2'r,4's,7'r,9'r,10'r,11's)-2'-(hydroxymethyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-ene-4',10',11'-triol
1,2,6,7-tetrahydro-4,8-dimethylphenanthro[3,4-b]furan-1,2,9-triol
{"Ingredient_id": "HBIN000679","Ingredient_name": "1,2,6,7-tetrahydro-4,8-dimethylphenanthro[3,4-b]furan-1,2,9-triol","Alias": "NA","Ingredient_formula": "C18H18O4","Ingredient_Smile": "NA","Ingredient_weight": "298.338","OB_score": "NA","CAS_id": "199597-55-2","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9602","PubChem_id": "NA","DrugBank_id": "NA"}
1α-hydroxy-3-deoxypseudoanisatin
{"Ingredient_id": "HBIN002307","Ingredient_name": "1\u03b1-hydroxy-3-deoxypseudoanisatin","Alias": "NA","Ingredient_formula": "C15H22O6","Ingredient_Smile": "CC1C(=O)CC23CC(=O)OCC1(C2(C(CC3(C)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9988","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1α-hydroxy-6-deoxypseudoanisatin
{"Ingredient_id": "HBIN002308","Ingredient_name": "1\u03b1-hydroxy-6-deoxypseudoanisatin","Alias": "NA","Ingredient_formula": "C15H22O6","Ingredient_Smile": "CC1C(=O)CC23CC(=O)OCC1(C2(C(CC3(C)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9989","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-c-methyl-d-erythritol 1-o-β-d-fructofuranoside
{"Ingredient_id": "HBIN005466","Ingredient_name": "2-c-methyl-d-erythritol 1-o-\u03b2-d-fructofuranoside","Alias": "NA","Ingredient_formula": "C11H22O9","Ingredient_Smile": "CC(COC1(C(C(C(O1)CO)O)O)CO)(C(CO)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14413","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-c-methyl-d-erythritol 1-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN005467","Ingredient_name": "2-c-methyl-d-erythritol 1-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C11H22O9","Ingredient_Smile": "CC(COC1(C(C(C(O1)CO)O)O)CO)(C(CO)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14416","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-c-methyl-d-erythritol 3-o-β-d-fructofuranoside
{"Ingredient_id": "HBIN005468","Ingredient_name": "2-c-methyl-d-erythritol 3-o-\u03b2-d-fructofuranoside","Alias": "NA","Ingredient_formula": "C11H22O9","Ingredient_Smile": "CC(CO)(C(CO)OC1(C(C(C(O1)CO)O)O)CO)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14414","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-c-methyl-d-erythritol 3-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN005469","Ingredient_name": "2-c-methyl-d-erythritol 3-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C11H22O9","Ingredient_Smile": "CC(CO)(C(CO)OC1(C(C(C(O1)CO)O)O)CO)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14417","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-c-methyl-d-erythritol 4-o-β-d-fructofuranoside
{"Ingredient_id": "HBIN005470","Ingredient_name": "2-c-methyl-d-erythritol 4-o-\u03b2-d-fructofuranoside","Alias": "NA","Ingredient_formula": "C11H22O9","Ingredient_Smile": "CC(CO)(C(COC1(C(C(C(O1)CO)O)O)CO)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14415","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-c-methyl-d-erythritol 4-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN005471","Ingredient_name": "2-c-methyl-d-erythritol 4-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C11H22O9","Ingredient_Smile": "CC(CO)(C(COC1(C(C(C(O1)CO)O)O)CO)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14418","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2s)-hydroxy-6-deoxypseudoanisatin
{"Ingredient_id": "HBIN006813","Ingredient_name": "(2s)-hydroxy-6-deoxypseudoanisatin","Alias": "NA","Ingredient_formula": "C15H22O6","Ingredient_Smile": "CC1C(C(C2(C13CC(=O)C(C2(COC(=O)C3)C)C)O)O)O","Ingredient_weight": "298.33 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9990","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101254353","DrugBank_id": "NA"}
4-[(2s,3r)-3-methyl-7-((e)-1-propenyl)-2,3-di-hydro-1,4-benzodioxin-2-yl]-1,3-benzenediol
{"Ingredient_id": "HBIN009890","Ingredient_name": "4-[(2s,3r)-3-methyl-7-((e)-1-propenyl)-2,3-di-hydro-1,4-benzodioxin-2-yl]-1,3-benzenediol","Alias": "NA","Ingredient_formula": "C18H18O4","Ingredient_Smile": "CC=CC1=CC2=C(C=C1)OC(C(O2)C3=C(C=C(C=C3)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14680","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-[(2s,3s)-3-methyl-7-((e)-1-propenyl)-2,3-di-hydro-1,4-benzodioxin-2-yl]-1,3-benzenediol
{"Ingredient_id": "HBIN009893","Ingredient_name": "4-[(2s,3s)-3-methyl-7-((e)-1-propenyl)-2,3-di-hydro-1,4-benzodioxin-2-yl]-1,3-benzenediol","Alias": "NA","Ingredient_formula": "C18H18O4","Ingredient_Smile": "CC=CC1=CC2=C(C=C1)OC(C(O2)C3=C(C=C(C=C3)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14681","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4',6'-dihydroxy-3',5'-dimethyl-2'-methoxychal-cone
{"Ingredient_id": "HBIN010073","Ingredient_name": "4',6'-dihydroxy-3',5'-dimethyl-2'-methoxychal-cone","Alias": "NA","Ingredient_formula": "C18H18O4","Ingredient_Smile": "CC1=C(C(=C(C(=C1O)C(=O)C=CC2=CC=CC=C2)OC)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5856","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
amoenin
{"Ingredient_id": "HBIN015879","Ingredient_name": "amoenin","Alias": "NA","Ingredient_formula": "C15H22O6","Ingredient_Smile": "CC(C)C1C2C(C3(C(C1C(=O)O2)(CC4C3(O4)CO)O)C)O","Ingredient_weight": "298.33","OB_score": "NA","CAS_id": "70219-71-5","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6835","PubChem_id": "101967060","DrugBank_id": "NA"}
bilatriene
{"Ingredient_id": "HBIN018506","Ingredient_name": "bilatriene","Alias": "NA","Ingredient_formula": "C19H14N4","Ingredient_Smile": "C1=CC(=CC2=NC(=CC3=CC=C(N3)C=C4C=CC=N4)C=C2)N=C1","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2373","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1r,2s,4s,5s,8r,9s,10s)-4,9,10-trihydroxy-2,8,9-trimethyl-6,13-dioxatetracyclo[8.3.1.0¹,⁵.0⁵,⁸]tetradecan-12-one
4-[(2r,3ar,5'r,6ar)-6,6-dimethyl-5-oxo-dihydro-3h-spiro[furo[3,2-b]furan-2,2'-oxolan]-5'-yl]butanoic acid
5-(hept-1-en-1-yl)-6,7-dihydroxy-4-(hydroxymethyl)-3a,6,7,7a-tetrahydro-1,3-benzodioxol-2-one
(1'r,2's,3's,4's,6'r)-1',3',4',6'-tetrahydroxy-2'-(hydroxymethyl)-2',4',6'-trimethyl-1',3'-dihydrospiro[cyclopropane-1,5'-inden]-7'-one
(3as,6s,7s,7ar)-4-[(1e)-hept-1-en-1-yl]-6,7-dihydroxy-5-(hydroxymethyl)-3a,6,7,7a-tetrahydro-1,3-benzodioxol-2-one
4,9,10-trihydroxy-2,8,9-trimethyl-6,13-dioxatetracyclo[8.3.1.0¹,⁵.0⁵,⁸]tetradecan-12-one
2-[5-(3-hydroxypropyl)-1-benzofuran-2-yl]-5-methoxyphenol
7-[2-(hydroxymethyl)-3-methoxyphenyl]hept-6-ene-2,3,4,5-tetrol
2-(3-hydroxy-2,4,5-trimethylphenoxy)-6-methyloxane-3,4,5-triol
(1s,2r,5r,6s,10r,13r)-5,10,13-trihydroxy-2,6,13-trimethyl-8-oxatricyclo[4.4.3.0¹,⁵]tridecane-9,12-dione
(1r,3s,4r,5s)-1-[2-(1,3-oxazol-5-ylmethyl)-1,3-oxazol-4-yl]hexane-1,3,4,5-tetrol
(2e,4s,5s)-4,5-dihydroxy-1-(5-oxooxolan-2-yl)hex-2-en-1-yl (2e)-2-methylbut-2-enoate
10-hydroperoxy-2-isopropyl-5-methyl-11,12-dioxatricyclo[5.3.2.0¹,⁵]dodec-8-ene-8-carboxylic acid
2-(3-hydroxy-5-methoxy-2,4-dimethylphenyl)-5-methyl-1-benzofuran-4-ol
(4s,5r,7e)-7-(hexa-2,4-diyn-1-ylidene)-1,6-dioxaspiro[4.4]nona-2,8-dien-4-yl 3-methylbutanoate
(3s,4e,6e)-1-(acetyloxy)tetradeca-4,6-dien-8,10,12-triyn-3-yl acetate
(1r,2r,4s,5r,6s,13r)-4,5,13-trihydroxy-2,6,13-trimethyl-8-oxatricyclo[4.4.3.0¹,⁵]tridecane-9,12-dione
7,11-dihydroxy-6,6-bis(hydroxymethyl)-2,7-dimethyl-9-oxatricyclo[6.3.1.0¹,⁵]dodec-4-en-10-one
2,7,8-trihydroxy-6,7,13-trimethyl-4,9-dioxatetracyclo[6.5.1.0¹,¹⁰.0⁶,¹⁰]tetradecan-3-one
2-phenylethyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
1-{2,4-dihydroxy-6-[2-(4-hydroxyphenyl)ethenyl]phenyl}-2-methylpropan-1-one
2-benzoyl-4-(3-methylbut-2-en-1-yl)benzene-1,3,5-triol
4-[(2s,5s)-5-(4-hydroxyphenyl)-3,4-dimethyl-2,5-dihydrofuran-2-yl]benzene-1,2-diol
4,5,13-trihydroxy-2,6,13-trimethyl-8-oxatricyclo[4.4.3.0¹,⁵]tridecane-9,12-dione
1',3',4',6'-tetrahydroxy-2'-(hydroxymethyl)-2',4',6'-trimethyl-1',3'-dihydrospiro[cyclopropane-1,5'-inden]-7'-one
(2s,3s,4r,5r,6e)-7-[2-(hydroxymethyl)-3-methoxyphenyl]hept-6-ene-2,3,4,5-tetrol
4-hydroxy-6,6,8-trimethyl-2-phenyl-2,3-dihydro-1-benzopyran-5,7-dione
methyl 2-[(6z)-6-[(2e)-1-hydroxy-3-phenylprop-2-en-1-ylidene]-5-oxocyclohex-3-en-1-yl]acetate
2,2,4-trimethyl-6-[(2e)-3-phenylprop-2-enoyl]cyclohexane-1,3,5-trione
4,13-dihydroxy-5,9-dimethyl-11,14,15-trioxatetracyclo[11.2.1.0¹,⁵.0⁸,¹²]hexadecan-10-one
1-phenyl-3-(2,3,4-trimethoxyphenyl)prop-2-en-1-one
4-[(1r,3as,4r,6as)-4-(4-hydroxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]phenol
(2s)-7-hydroxy-5-methoxy-6,8-dimethyl-2-phenyl-2,3-dihydro-1-benzopyran-4-one
(2e)-3-phenyl-1-(2,4,6-trimethoxyphenyl)prop-2-en-1-one
3,7,11-trihydroxy-5-(hydroxymethyl)-11-isopropyl-6-methyl-9-oxatricyclo[6.2.1.0²,⁶]undec-4-en-10-one
(1r,4r,5s,12s,13s)-4,13-dihydroxy-5,9-dimethyl-11,14,15-trioxatetracyclo[11.2.1.0¹,⁵.0⁸,¹²]hexadecan-10-one
(2e)-1-(4-hydroxy-3,6-dimethoxy-2-methylphenyl)-3-phenylprop-2-en-1-one
2-(4-hydroxy-5-isopropyl-2-methylphenoxy)oxane-3,4,5-triol
(1'r,2's,3's,4's,6's)-1',3',4',6'-tetrahydroxy-2'-(hydroxymethyl)-2',4',6'-trimethyl-1',3'-dihydrospiro[cyclopropane-1,5'-inden]-7'-one
(3r,3ar,7r,9r,11ar)-7-hydroperoxy-3,9-dihydroxy-3,10-dimethyl-6-methylidene-3ah,4h,5h,7h,8h,9h,11ah-cyclodeca[b]furan-2-one
(1r,6r,7r,8s,10r,11s,13r)-7,8,11-trihydroxy-6,7,13-trimethyl-4,9-dioxatetracyclo[6.5.1.0¹,¹⁰.0⁶,¹⁰]tetradecan-3-one
(2s,3r,4r,5r,6s)-2-(3-hydroxy-2,5,6-trimethylphenoxy)-6-methyloxane-3,4,5-triol
(3ar,6r,7s,7as)-5-[(1e)-hept-1-en-1-yl]-6,7-dihydroxy-4-(hydroxymethyl)-3a,6,7,7a-tetrahydro-1,3-benzodioxol-2-one
(1r,2r,7r,8r,11r)-7,11-dihydroxy-6,6-bis(hydroxymethyl)-2,7-dimethyl-9-oxatricyclo[6.3.1.0¹,⁵]dodec-4-en-10-one
(1r,5s,8s,9r)-8-hydroxy-9-[(1s)-1-hydroxyethyl]-5,9-dimethyl-4,11-dioxatricyclo[6.5.0.0¹,⁵]tridecane-3,12-dione
(1r,2e,4s,5r)-4,5-dihydroxy-1-[(2r)-5-oxooxolan-2-yl]hex-2-en-1-yl (2e)-2-methylbut-2-enoate
4,5,11-trihydroxy-2,6,11-trimethyl-8-oxatricyclo[4.4.3.0¹,⁵]tridecane-9,12-dione
5-hydroxy-6,8,8-trimethyl-2-phenyl-2,3-dihydro-1-benzopyran-4,7-dione
8,9-dihydroxy-3-methoxy-2,2,6-trimethylanthracen-1-one
(3as,6r,7s,7ar)-4-[(1e)-hept-1-en-1-yl]-6,7-dihydroxy-5-(hydroxymethyl)-3a,6,7,7a-tetrahydro-1,3-benzodioxol-2-one
4-[5-(4-hydroxyphenyl)-3,4-dimethyl-2,5-dihydrofuran-2-yl]benzene-1,2-diol
7-(hexa-2,4-diyn-1-ylidene)-1,6-dioxaspiro[4.4]nona-2,8-dien-4-yl 3-methylbutanoate
2,8-dihydroxy-6-(hydroxymethyl)-12-isopropyl-7-methyl-5,10-dioxatetracyclo[7.2.1.0²,⁷.0⁴,⁶]dodecan-11-one
(2z,4e)-3-methyl-5-[(1r,2r,3r,5s,8s)-2,3,8-trihydroxy-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-8-yl]penta-2,4-dienoic acid
5-[2-hydroxy-5-(prop-2-en-1-yl)phenyl]-2-(hydroxymethyl)-2,3-dihydro-1-benzofuran-3-ol
4-(hept-1-en-1-yl)-6,7-dihydroxy-5-(hydroxymethyl)-3a,6,7,7a-tetrahydro-1,3-benzodioxol-2-one
(2z)-2-[(2e)-1-hydroxy-3-phenylprop-2-en-1-ylidene]-5-methoxy-6,6-dimethylcyclohex-4-ene-1,3-dione
[(3as,4r,10as)-10,10-dihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methyl acetate
C11H18N6O4 (298.13894680000004)